• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

反义寡聚脱氧核苷酸对NF-κB-Rel A表达的抑制作用可抑制尿激酶型纤溶酶原激活剂(uPA)的合成,但不影响其抑制剂PAI-1的合成。

Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.

作者信息

Reuning U, Wilhelm O, Nishiguchi T, Guerrini L, Blasi F, Graeff H, Schmitt M

机构信息

Frauenklinik, Technischen Universität München, Klinikum rechts der Isar, Germany.

出版信息

Nucleic Acids Res. 1995 Oct 11;23(19):3887-93. doi: 10.1093/nar/23.19.3887.

DOI:10.1093/nar/23.19.3887
PMID:7479032
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC307306/
Abstract

The essential role of urokinase-type plasminogen activator (uPA) in tumor invasion and metastasis stresses the necessity of a fine-tuned cellular control over its expression. It has been shown that changes in uPA directly correlate with changes in cell invasiveness. We examined the role of Rel-related proteins in uPA synthesis by human ovarian cancer cells by inhibiting their expression using the antisense (AS) oligodeoxynucleotide (ODN) technology. Exposure of OV-MZ-6 cells to 10 microM phosphorothioate (PS)-derivatized AS-ODN directed to Rel A led to a maximal 50% decrease of uPA antigen in cell lysates and a 70% reduction in cell cultures supernatants accompanied by a significant transient decline in uPA mRNA levels. Antisense-PS-ODN directed to NF-kappa B1 (p50) or c-rel had no effect on uPA protein expression. AS-PS-ODN directed to Rel A also affected the proteolytic capacity of OV-MZ-6 cells reflected by an approximately 70% decrease in the fibrinolytic capacity of the cells within 24 h compared to untreated controls. AS-PS-ODN directed to I kappa B alpha expression increased uPA in cell culture supernatants up to 50%. uPA receptor (uPAR) production and synthesis of plasminogen activator inhibitor type-1 (PAI-1) were not altered by either AS-PS-ODN applied. Western blot and gel retardation analyses revealed constitutive expression of Rel-related proteins in nuclear protein extracts of OV-MZ-6 cells. Thus these proteins seem to be implicated in uPA regulation and may thereby contribute to tumor spread and metastasis.

摘要

尿激酶型纤溶酶原激活剂(uPA)在肿瘤侵袭和转移中起着至关重要的作用,这凸显了对其表达进行精确细胞调控的必要性。研究表明,uPA的变化与细胞侵袭性的变化直接相关。我们通过使用反义(AS)寡脱氧核苷酸(ODN)技术抑制人卵巢癌细胞中Rel相关蛋白的表达,来研究它们在uPA合成中的作用。将OV-MZ-6细胞暴露于针对Rel A的10 microM硫代磷酸酯(PS)衍生的AS-ODN中,导致细胞裂解物中uPA抗原最大减少50%,细胞培养上清液中减少70%,同时uPA mRNA水平显著短暂下降。针对NF-κB1(p50)或c-rel的反义PS-ODN对uPA蛋白表达没有影响。针对Rel A的AS-PS-ODN也影响了OV-MZ-6细胞的蛋白水解能力,与未处理的对照相比,24小时内细胞的纤溶能力下降了约70%。针对IκBα表达的AS-PS-ODN使细胞培养上清液中的uPA增加了50%。所应用的任何一种AS-PS-ODN都未改变uPA受体(uPAR)的产生以及1型纤溶酶原激活剂抑制剂(PAI-1)的合成。蛋白质印迹和凝胶阻滞分析显示,Rel相关蛋白在OV-MZ-6细胞核蛋白提取物中组成性表达。因此,这些蛋白似乎与uPA的调节有关,从而可能促进肿瘤的扩散和转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/307306/bda4dc65fe2a/nar00019-0095-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/307306/13a80afc7858/nar00019-0094-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/307306/bda4dc65fe2a/nar00019-0095-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/307306/13a80afc7858/nar00019-0094-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ec/307306/bda4dc65fe2a/nar00019-0095-a.jpg

相似文献

1
Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.反义寡聚脱氧核苷酸对NF-κB-Rel A表达的抑制作用可抑制尿激酶型纤溶酶原激活剂(uPA)的合成,但不影响其抑制剂PAI-1的合成。
Nucleic Acids Res. 1995 Oct 11;23(19):3887-93. doi: 10.1093/nar/23.19.3887.
2
Expressions of urokinase-type plasminogen activator, its receptor and plasminogen activator inhibitor-1 in gastric cancer cells and effects of Helicobacter pylori.尿激酶型纤溶酶原激活剂、其受体及纤溶酶原激活剂抑制剂-1在胃癌细胞中的表达及幽门螺杆菌的作用
Scand J Gastroenterol. 2005 Jul;40(7):783-93. doi: 10.1080/00365520510015665.
3
Rel transcription factors contribute to elevated urokinase expression in human ovarian carcinoma cells.Rel转录因子促使人类卵巢癌细胞中尿激酶表达升高。
Eur J Biochem. 1999 Jan;259(1-2):143-8. doi: 10.1046/j.1432-1327.1999.00014.x.
4
Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer.晚期卵巢癌中编码尿激酶型纤溶酶原激活剂(uPA)及其抑制剂PAI-1的基因突变分析。
Electrophoresis. 1997 May;18(5):686-9. doi: 10.1002/elps.1150180505.
5
Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.用于测定乳腺癌患者原发肿瘤组织中尿激酶型纤溶酶原激活剂和纤溶酶原激活剂抑制剂1 mRNA的定量逆转录聚合酶链反应检测:与酶联免疫吸附测定法进行抗原定量的比较
Int J Mol Med. 2008 Feb;21(2):251-9.
6
β-Catenin and NF-κB cooperate to regulate the uPA/uPAR system in cancer cells.β-连环蛋白和 NF-κB 合作调节癌细胞中的 uPA/uPAR 系统。
Int J Cancer. 2011 Mar 15;128(6):1280-92. doi: 10.1002/ijc.25455.
7
Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.前列腺素E2调节大鼠颅骨成骨细胞原代培养物中纤溶酶原激活物同工酶、尿激酶受体和纤溶酶原激活物抑制剂-1的产生。
J Cell Physiol. 1995 Dec;165(3):521-9. doi: 10.1002/jcp.1041650310.
8
Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.通过与尿激酶型纤溶酶原激活剂相互作用,尿激酶特异性表面受体的高表达得以维持。
Mol Carcinog. 2007 Mar;46(3):165-75. doi: 10.1002/mc.20249.
9
[Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells].[核因子-κB诱饵转染对SKOV3细胞的核因子-κB活性及血管内皮生长因子/尿激酶型纤溶酶原激活剂/细胞间黏附分子-1水平的影响]
Zhonghua Fu Chan Ke Za Zhi. 2004 Aug;39(8):533-7.
10
Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells.重组可溶性尿激酶受体作为尿激酶型纤溶酶原激活剂(uPA)的清除剂。对人卵巢癌细胞增殖和侵袭的抑制作用。
FEBS Lett. 1994 Jan 10;337(2):131-4. doi: 10.1016/0014-5793(94)80259-9.

引用本文的文献

1
NF-κB signaling in neoplastic transition from epithelial to mesenchymal phenotype.NF-κB 信号通路在肿瘤上皮-间充质转化过程中的作用。
Cell Commun Signal. 2023 Oct 18;21(1):291. doi: 10.1186/s12964-023-01207-z.
2
Prognostic significance of uPA and uPAR expression in patients with cervical cancer undergoing radiotherapy.uPA和uPAR表达在接受放疗的宫颈癌患者中的预后意义
Oncol Lett. 2021 May;21(5):423. doi: 10.3892/ol.2021.12684. Epub 2021 Mar 29.
3
Effect of NF-κB p65 antisense oligodeoxynucleotide on transdifferentiation of normal human lens epithelial cells induced by transforming growth factor-β2.

本文引用的文献

1
NF-kappa B and Rel: participants in a multiform transcriptional regulatory system.核因子-κB与Rel:一个多形式转录调控系统的参与者
Int Rev Cytol. 1993;143:1-62. doi: 10.1016/s0074-7696(08)61873-2.
2
Prevention of metastasis by inhibition of the urokinase receptor.通过抑制尿激酶受体预防转移。
Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5021-5. doi: 10.1073/pnas.90.11.5021.
3
Purification and cDNA cloning of a transcription factor which functionally cooperates within a cAMP regulatory unit in the porcine uPA gene.猪尿激酶型纤溶酶原激活剂(uPA)基因中一个在cAMP调节单元内发挥功能协同作用的转录因子的纯化及cDNA克隆
核因子-κB p65反义寡脱氧核苷酸对转化生长因子-β2诱导的正常人晶状体上皮细胞转分化的影响
Int J Ophthalmol. 2016 Jan 18;9(1):29-32. doi: 10.18240/ijo.2016.01.05. eCollection 2016.
4
Effect of antisense oligodeoxynucleotide targeted against NF-κB/P65 on cell proliferation and tumorigenesis of gastric cancer.反义寡核苷酸针对 NF-κB/P65 对胃癌细胞增殖和致瘤性的影响。
Clin Exp Med. 2013 Feb;13(1):11-9. doi: 10.1007/s10238-011-0174-1. Epub 2012 Jan 11.
5
Loss of inhibitor of growth (ING-4) is implicated in the pathogenesis and progression of human astrocytomas.生长抑制剂(ING-4)的缺失与人类星形细胞瘤的发病机制和进展有关。
Brain Pathol. 2010 Mar;20(2):490-7. doi: 10.1111/j.1750-3639.2009.00325.x. Epub 2009 Aug 6.
6
Effect of antisense oligodeoxynucleotide directed to NF-kappa B-RelA on Bcl-XL mRNA in extended drug resistance leukemia cell line HL-60/E6.针对NF-κB-RelA的反义寡脱氧核苷酸对耐多药白血病细胞系HL-60/E6中Bcl-XL mRNA的影响。
J Tongji Med Univ. 2001;21(1):32-4. doi: 10.1007/BF02888031.
Nucleic Acids Res. 1993 Apr 25;21(8):1845-52. doi: 10.1093/nar/21.8.1845.
4
Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness.尿激酶与尿激酶受体:一个调节细胞迁移和侵袭的旁分泌/自分泌系统。
Bioessays. 1993 Feb;15(2):105-11. doi: 10.1002/bies.950150206.
5
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?反义寡核苷酸作为治疗药物——子弹真的神奇吗?
Science. 1993 Aug 20;261(5124):1004-12. doi: 10.1126/science.8351515.
6
Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells.重组可溶性尿激酶受体作为尿激酶型纤溶酶原激活剂(uPA)的清除剂。对人卵巢癌细胞增殖和侵袭的抑制作用。
FEBS Lett. 1994 Jan 10;337(2):131-4. doi: 10.1016/0014-5793(94)80259-9.
7
Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.核因子-κB p65亚基的反义抑制可阻断肿瘤发生并导致肿瘤消退。
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9901-5. doi: 10.1073/pnas.90.21.9901.
8
Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes.针对核因子-κB p65亚基的反义寡核苷酸可阻断CD11b表达并改变分化型HL-60粒细胞的黏附特性。
Blood. 1993 Jul 15;82(2):625-32.
9
Gene inhibition using antisense oligodeoxynucleotides.使用反义寡脱氧核苷酸进行基因抑制。
Nature. 1994 Nov 24;372(6504):333-5. doi: 10.1038/372333a0.
10
Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation.反义RNA表达对IκBα调节的破坏导致恶性转化。
Oncogene. 1994 Nov;9(11):3189-97.